Molecular signature associated with cladribine treatment in patients with multiple sclerosis

IntroductionLittle is known about the molecular profiling associated with the effect of cladribine in patients with multiple sclerosis (MS). Here, we aimed first to characterize the transcriptomic and proteomic profiles induced by cladribine in blood cells, and second to identify potential treatment...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Luisa M. Villar, Lucienne Costa-Frossard, Mireia Ferrer, Alex Sanchez, Eva Borràs, Eduard Sabidó, Carmen Espejo, Xavier Montalban, Manuel Comabella
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2023-07-01
Σειρά:	Frontiers in Immunology
Θέματα:	multiple sclerosis cladribine biomarkers omics bioinformatics
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1233546/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!